Guidelines (2nd Edition, 2007) of the Brazilian Society of Cardiology on unstable angina and acute myocardial infarction without ST-segment elevation;Diretrizes (IIa edição, 2007) da Sociedade Brasileira de Cardiologia sobre angina instável e infarto agudo do miocárdio sem supradesnível do segmento ST

Arquivos Brasileiros de Cardiologia

Volumn 89, Issue 4, 2007, Pages 89-131

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE COURSE; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; ERGONOMICS; HEART ARRHYTHMIA; HEART MUSCLE REVASCULARIZATION; HUMAN; MORBIDITY; MORTALITY; RECURRENT DISEASE; REVIEW; RISK FACTOR; ST SEGMENT; STATISTICAL SIGNIFICANCE; T WAVE INVERSION; UNSTABLE ANGINA PECTORIS; AGED; ARTICLE; BRAZIL; CONFLICT OF INTEREST; ELECTROCARDIOGRAPHY; ERGOMETRY; EVIDENCE BASED MEDICINE; FEMALE; HEART INFARCTION; MALE; MEDICAL SOCIETY; OXYGEN THERAPY; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; STANDARD; TIME;

BIOLOGICAL MARKER;

AGED; ANGINA, UNSTABLE; BIOLOGICAL MARKERS; BRAZIL; CONFLICT OF INTEREST; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; ERGOMETRY; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL REVASCULARIZATION; OXYGEN INHALATION THERAPY; RISK FACTORS; SOCIETIES, MEDICAL; TIME FACTORS;

EID: 37349058191     PISSN: 0066782X     EISSN: 16784170     Source Type: Journal    
DOI: None     Document Type: Review

References (291)

1. Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Results of the TIMI IIIB Trial. Thrombolysis in Myocardial Ischemia. Circulation 1994 Apr;89(4):1545-56.
2. Theroux P, Fuster V. Acute coronary syndromes: unstable angina and non-Q-wave myocardial infarction. Circulation 1998 Mar 31;97(12):1195-206.
3. Zaacks SM, Liebson PR, Calvin JE, Parrillo JE, Klein LW. Unstable angina and non-Q wave myocardial infarction: does the clinical diagnosis have therapeutic implications? J Am Coll Cardiol 1999 Jan;33(1):107-18.
4. Calvin JE, Klein LW, VandenBerg BJ, Meyer P, Ramirez-Morgen LM, Parrillo JE. Clinical predictors easily obtained at presentation predict resource utilization in unstable angina. Am Heart J 1998 Sep;136(3):373-81.
5. Kong DF, Blazing MA, O'Connor CM. The health care burden of unstable angina. Cardiol Clin 1999 May;17(2):247-61.
6. Braunwald E, Jones RH, Mark DB, Brown J, Brown L, Cheitlin MD, et al. Diagnosing and managing unstable angina. Agency for Health Care Policy and Research. Circulation 1994 Jul;90(1):613-22.
7. Braunwald E. Unstable angina. A classification. Circulation 1989 Aug;80(2):410-4.
8. Calvin JE, Klein LW, VandenBerg BJ, Meyer P, Condon JV, Snell RJ, et al. Risk stratification in unstable angina. Prospective validation of the Braunwald classification. JAMA 1995 Jan 11;273(2):136-41.
9. van Miltenburg-van Zijl AJ, Simoons ML, Veerhoek RJ, Bossuyt PM. Incidence and follow-up of Braunwald subgroups in unstable angina pectoris. J Am Coll Cardiol 1995 May;25(6):1286-92.
10. Lopez de SE, Lopez-Sendon J, Rubio R, Delcan JL. [Validity of different classifications of unstable angina]. Rev Esp Cardiol 1999;52 Suppl 1:46-54.
11. Bazzino O, Diaz R, Tajer C, Paviotti C, Mele E, Trivi M, et al. Clinical predictors of in-hospital prognosis in unstable angina: ECLA 3. The ECLA Collaborative Group. Am Heart J 1999 Feb;137(2):322-31.
12. Armstrong PW, Fu Y, Chang WC, Topol EJ, Granger CB, Betriu A, et al. Acute coronary syndromes in the GUSTO-IIb trial: prognostic insights and impact of recurrent ischemia. The GUSTO-IIb Investigators. Circulation 1998 Nov 3;98(18):1860-8.
13. Hamm CW, Braunwald E. A classification of unstable angina revisited. Circulation 2000 Jul 4;102(1):118-22.
14. Braunwald E, Antman EM, Beasley JW, Califf RM, Cheitlin MD, Hochman JS, et al. ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol 2000 Sep;36(3):970-1062.
15. Freeman MR, Williams AE, Chisholm RJ, Armstrong PW. Intracoronary thrombus and complex morphology in unstable angina. Relation to timing of angiography and in-hospital cardiac events. Circulation 1989 Jul;80(1):17-23.
16. Antman EM, Cohen M, Bernink PJ, McCabe CH, Horacek T, Papuchis G, et al. The TIMI risk score for unstable angina/non-ST elevation MI: A method for prognostication and therapeutic decision making. JAMA 2000 Aug 16;284(7):835-42.
17. United States Department of Health and Human Services Ncfhs. Advance report of final mortality statistics. 39 (suppl 7), I-48. 1990. Washington, DC. Ref Type: Generic
18. United States Department of Health and Human Services Ncfhs. National hospital discharge survey. 1987. Washington, DC. Ref Type: Generic
19. Keller NM, Feit F. Coronary artery disease in the geriatric population. Prog Cardiovasc Dis 1996 Mar;38(5):407-18.
20. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Lancet 1988 Aug 13;2(8607):349-60.
21. Sokolyk S, Tresch D. Treatment of myocardial infarction in elderly patients. Compr Ther 1994;20(10):537-44.
22. Stone PH, Thompson B, Anderson HV, Kronenberg MW, Gibson RS, Rogers WJ, et al. Influence of race, sex, and age on management of unstable angina and non-Q-wave myocardial infarction: The TIMI III registry. JAMA 1996 Apr 10;275(14):1104-12.
23. Kleiman NS, Anderson HV, Rogers WJ, Theroux P, Thompson B, Stone PH. Comparison of outcome of patients with unstable angina and non-Q-wave acute myocardial infarction with and without prior coronary artery bypass grafting (Thrombolysis in Myocardial Ischemia III Registry). Am J Cardiol 1996 Feb 1;77(4):227-31.
24. Barbash GI, Reiner J, White HD, Wilcox RG, Armstrong PW, Sadowski Z, et al. Evaluation of paradoxic beneficial effects of smoking in patients receiving thrombolytic therapy for acute myocardial infarction: mechanism of the "smoker's paradox" from the GUSTO-I trial, with angiographic insights. Global Utilization of Streptokinase and Tissue-Plasminogen Activator for Occluded Coronary Arteries. J Am Coll Cardiol 1995 Nov 1;26(5):1222-9.
25. Barbash GI, White HD, Modan M, Diaz R, Hampton JR, Heikkila J, et al. Significance of smoking in patients receiving thrombolytic therapy for acute myocardial infarction. Experience gleaned from the International Tissue Plasminogen Activator/Streptokinase Mortality Trial. Circulation 1993 Jan;87(1):53-8.
26. Yeghiazarians Y, Braunstein JB, Askari A, Stone PH. Unstable angina pectoris. N Engl J Med 2000 Jan 13;342(2):101-14.
27. Braunwald E, Califf RM, Cannon CP, Fox KA, Fuster V, Gibler WB, et al. Redefining medical treatment in the management of unstable angina. Am J Med 2000 Jan;108(1):41-53.
28. Bassan R, Gamarski R, Pimenta L, Volschan A, Scofano M, Dohmann HF, et al. Efficacy of a diagnostic strategy for patients with chest pain and no ST-segment elevation in the emergency room. Arq Bras Cardiol 2000 May;74(5):405-17.
29. Lopez BL, Fernandez-Ortiz A, Bueno ZH, Coma C, I, Lidon Corbi RM, Cequier FA, et al. [Clinical practice guidelines of the Spanish Society of Cardiology on unstable angina/infarction without ST elevation]. Rev Esp Cardiol 2000 Jun;53(6):838-50.
30. Yusuf S, Flather M, Pogue J, Hunt D, Varigos J, Piegas L, et al. Variations between countries in invasive cardiac procedures and outcomes in patients with suspected unstable angina or myocardial infarction without initial ST elevation. OASIS (Organisation to Assess Strategies for Ischaemic Syndromes) Registry Investigators. Lancet 1998 Aug 15;352(9127):507-14.
31. Kennon S, Suliman A, MacCallum PK, Ranjadayalan K, Wilkinson P, Timmis AD. Clinical characteristics determining the mode of presentation in patients with acute coronary syndromes. J Am Coll Cardiol 1998 Dec;32(7):2018-22.
32. Col NF, Yarzbski J, Gore JM, Alpert JS, Goldberg RJ. Does aspirin consumption affect the presentation or severity of acute myocardial infarction? Arch Intern Med 1995 Jul 10;155(13):1386-9.
33. Abdelnoor M, Landmark K. Infarct size is reduced and the frequency of non-Q-wave myocardial infarctions is increased in patients using aspirin at the onset of symptoms. Cardiology 1999;91(2):119-26.
34. Cannon CP, McCabe CH, Stone PH, Rogers WJ, Schactman M, Thompson BW, et al. The electrocardiogram predicts one-year outcome of patients with unstable angina and non-Q wave myocardial infarction: results of the TIMI III Registry ECG Ancillary Study. Thrombolysis in Myocardial Ischemia. J Am Coll Cardiol 1997 Jul;30(1):133-40.
35. Hochman JS, McCabe CH, Stone PH, Becker RC, Cannon CP, Feo-Fraulini T, et al. Outcome and profile of women and men presenting with acute coronary syndromes: a report from TIMI IIIB. TIMI Investigators. Thrombolysis in Myocardial Infarction. J Am Coll Cardiol 1997 Jul;30(1):141-8.
36. Boersma E, Pieper KS, Steyerberg EW, Wilcox RG, Chang WC, Lee KL, et al. Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation. Results from an international trial of 9461 patients. The PURSUIT Investigators. Circulation 2000 Jun 6;101(22):2557-67.
37. Zhao XQ, Theroux P, Snapinn SM, Sax FL. Intracoronary thrombus and platelet glycoprotein IIb/IIIa receptor blockade with tirofiban in unstable angina or non-Q-wave myocardial infarction. Angiographic results from the PRISM-PLUS trial (Platelet receptor inhibition for ischemic syndrome management in patients limited by unstable signs and symptoms). PRISM-PLUS Investigators. Circulation 1999 Oct 12;100(15):1609-15.
38. Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction. Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) Study Investigators. N Engl J Med 1998 May 21;338(21):1488-97.
39. Antman EM, Braunwald E. Acute Myocardial Infarction. Braunwald E, editor. Heart Disease. A Textbook of Cardiovascular Medicine. [5th edition], 1184-1288. 1997. Philadelphia, W. B. Saunders Company. Ref Type: Generic
40. Pfeffer MA, Braunwald E. Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation 1990 Apr;81(4):1161-72.
41. Levine HD. Subendocardial infarction in retrospect: pathologic, cardiographic, and ancillary features. Circulation 1985 Oct;72(4):790-800.
42. Bosch X, Theroux P, Pelletier GB, Sanz G, Roy D, Waters D. Clinical and angiographic features and prognostic significance of early postinfarction angina with and without electrocardiographic signs of transient ischemia. Am J Med 1991 Nov;91(5):493-501.
43. Gersh B.J., Braunwald E. Chronic Coronary Artery Disease. Braunwald E, editor. Heart Disease. A Textbook of Cardiovascular Medicine. [5th edition], 1289-1365. 1997. Philadelphia, W. B. Saunders Company. Ref Type: Generic
44. Gottlieb SO, Weisfeldt ML, Ouyang P, Mellits ED, Gerstenblith G. Silent ischemia predicts infarction and death during 2 year follow-up of unstable angina. J Am Coll Cardiol 1987 Oct;10(4):756-60.
45. Moliterno D.J., Granger CB. Differences between unstable angina and acute myocardial infarction. Topol EJ, editor. Acute Coronary Syndromes. 67-103. 1998. New York, Marcel Dekker. Ref Type: Generic
46. Gibbler W.B. Diagnosis of acute coronary syndromes in the emergency department. Topol EJ, editor. Acute Coronary Syndromes. 405-435. 1998. New York, Marcel Dekker. Ref Type: Generic
47. Newby L.K., Ohman E.M., Christenson R.H. The role of troponin and other markers for myocardial necrosis in risk stratification. Topol EJ, editor. Acute Coronary Syndromes. 405-435. 1998. New York, Marcel Dekker. Ref Type: Generic
48. Rouan GW, Lee TH, Cook EF, Brand DA, Weisberg MC, Goldman L. Clinical characteristics and outcome of acute myocardial infarction in patients with initially normal or nonspecific electrocardiograms (a report from the Multicenter Chest Pain Study). Am J Cardiol 1989 Nov 15;64(18):1087-92.
49. Brush JE, Jr., Brand DA, Acampora D, Chalmer B, Wackers FJ. Use of the initial electrocardiogram to predict in-hospital complications of acute myocardial infarction. N Engl J Med 1985 May 2;312(18):1137-41.
50. Krucoff MW, Green CE, Satler LF, Miller FC, Pallas RS, Kent KM, et al. Noninvasive detection of coronary artery patency using continuous ST-segment monitoring. Am J Cardiol 1986 Apr 15;57(11):916-22.
51. Justis DL, Hession WT. Accuracy of 22-lead ECG analysis for diagnosis of acute myocardial infarction and coronary artery disease in the emergency department: a comparison with 12-lead ECG. Ann Emerg Med 1992 Jan;21(1):1-9.
52. Mahon NG, Codd MB, McKenna CJ, O'Rorke C, McCann HA, Sugrue DD. Characteristics and outcomes in patients with acute myocardial infarction with ST-segment depression on initial electrocardiogram. Am Heart J 2000 Feb;139(2 Pt 1):311-9.
53. Cohen M, Hawkins L, Greenberg S, Fuster V. Usefulness of ST-segment changes in greater than or equal to 2 leads on the emergency room electrocardiogram in either unstable angina pectoris or non-Q-wave myocardial infarction in predicting outcome. Am J Cardiol 1991 Jun 15;67(16):1368-73.
54. Cohen M, Stinnett SS, Weatherley BD, Gurfinkel EP, Fromell GJ, Goodman SG, et al. Predictors of recurrent ischemic events and death in unstable coronary artery disease after treatment with combination antithrombotic therapy. Am Heart J 2000 Jun;139(6):962-70.
55. Farkouh ME, Smars PA, Reeder GS, Zinsmeister AR, Evans RW, Meloy TD, et al. A clinical trial of a chest-pain observation unit for patients with unstable angina. Chest Pain Evaluation in the Emergency Room (CHEER) Investigators. N Engl J Med 1998 Dec 24;339(26):1882-8.
56. Crenshaw BS, Ward SR, Granger CB, Stebbins AL, Topol EJ, Califf RM. Atrial fibrillation in the setting of acute myocardial infarction: the GUSTO-I experience. Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries. J Am Coll Cardiol 1997 Aug;30(2):406-13.
57. Newby KH, Thompson T, Stebbins A, Topol EJ, Califf RM, Natale A. Sustained ventricular arrhythmias in patients receiving thrombolytic therapy: incidence and outcomes. The GUSTO Investigators. Circulation 1998 Dec 8;98(23):2567-73.
58. Lee T.H., Goldman L. Serum enzymes assays in the diagnosis of acute myocardial infarction. Sox H., editor. Common diagnostic tests. Use and interpretation. 34-68. 1990. Philadelfia, ACP Press. Ref Type: Generic
59. Newby LK, Christenson RH, Ohman EM, Armstrong PW, Thompson TD, Lee KL, et al. Value of serial troponin T measures for early and late risk stratification in patients with acute coronary syndromes. The GUSTO-IIa Investigators. Circulation 1998 Nov 3;98(18):1853-9.
60. Mair J, Morandell D, Genser N, Lechleitner P, Dienstl F, Puschendorf B. Equivalent early sensitivities of myoglobin, creatine kinase MB mass, creatine kinase isoform ratios, and cardiac troponins I and T for acute myocardial infarction. Clin Chem 1995 Sep;41(9):1266-72.
61. Christenson RH, Duh SH. Evidence based approach to practice guides and decision thresholds for cardiac markers. Scand J Clin Lab Invest Suppl 1999;230:90-102.
62. Puleo PR, Meyer D, Wathen C, Tawa CB, Wheeler S, Hamburg RJ, et al. Use of a rapid assay of subforms of creatine kinase-MB to diagnose or rule out acute myocardial infarction. N Engl J Med 1994 Sep 1;331(9):561-6.
63. Zimmerman J, Fromm R, Meyer D, Boudreaux A, Wun CC, Smalling R, et al. Diagnostic marker cooperative study for the diagnosis of myocardial infarction. Circulation 1999 Apr 6;99(13):1671-7.
64. Ohman EM, Armstrong PW, Christenson RH, Granger CB, Katus HA, Hamm CW, et al. Cardiac troponin T levels for risk stratification in acute myocardial ischemia. GUSTO IIA Investigators. N Engl J Med 1996 Oct 31;335(18):1333-41.
65. Antman EM, Tanasijevic MJ, Thompson B, Schactman M, McCabe CH, Cannon CP, et al. Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N Engl J Med 1996 Oct 31;335(18):1342-9.
66. Polanczyk CA, Lee TH, Cook EF, Walls R, Wybenga D, Printy-Klein G, et al. Cardiac troponin I as a predictor of major cardiac events in emergency department patients with acute chest pain. J Am Coll Cardiol 1998 Jul;32(1):8-14.
67. Jaffe AS, Ravkilde J, Roberts R, Naslund U, Apple FS, Galvani M, et al. It's time for a change to a troponin standard. Circulation 2000 Sep 12;102(11):1216-20.
68. Cannon CP, Weintraub WS, Demopoulos LA, Vicari R, Frey MJ, Lakkis N, et al. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med 2001 Jun 21;344(25):1879-87.
69. Montague C, Kircher T. Myoglobin in the early evaluation of acute chest pain. Am J Clin Pathol 1995 Oct;104(4):472-6.
70. Polanczyk CA, Johnson PA, Cook EF, Lee TH. A proposed strategy for utilization of creatine kinase-MB and troponin I in the evaluation of acute chest pain. Am J Cardiol 1999 Apr 15;83(8):1175-9.
71. Cannon CP, Battler A, Brindis RG, Cox JL, Ellis SG, Every NR, et al. American College of Cardiology key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes. A report of the American College of Cardiology Task Force on Clinical Data Standards (Acute Coronary Syndromes Writing Committee). J Am Coll Cardiol 2001 Dec;38(7):2114-30.
72. Bahr RD. Acute outpatient care and comprehensive management of acute myocardial ischemia in chest pain emergency departments. Md Med J 1995 Sep;44(9):691-3.
73. Graff LG, Dallara J, Ross MA, Joseph AJ, Itzcovitz J, Andelman RP, et al. Impact on the care of the emergency department chest pain patient from the chest pain evaluation registry (CHEPER) study. Am J Cardiol 1997 Sep 1;80(5):563-8.
74. Myers J, Buchanan N, Smith D, Neutel J, Bowes E, Walsh D, et al. Individualized ramp treadmill. Observations on a new protocol. Chest 1992 May;101(5 Suppl):236S-41S.
75. Myers J, Buchanan N, Walsh D, Kraemer M, McAuley P, Hamilton-Wessler M, et al. Comparison of the ramp versus standard exercise protocols. J Am Coll Cardiol 1991 May;17(6):1334-42.
76. Myers J, Do D, Herbert W, Ribisl P, Froelicher VF. A nomogram to predict exercise capacity from a specific activity questionnaire and clinical data. Am J Cardiol 1994 Mar 15;73(8):591-6.
77. de Winter RJ, Koster RW, Schotveld JH, Sturk A, van Straalen JP, Sanders GT. Prognostic value of troponin T, myoglobin, and CK-MB mass in patients presenting with chest pain without acute myocardial infarction. Heart 1996 Mar;75(3):235-9.
78. Newby LK, Mark DB. The chest-pain unit - ready for prime time? N Engl J Med 1998 Dec 24;339(26):1930-2.
79. Routledge HC, Townend JN. Why does the heart rate response to exercise predict adverse cardiac events? Heart 2006 May;92(5):577-8.
80. Belardinelli R, Lacalaprice F, Carle F, Minnucci A, Cianci G, Perna G, et al. Exercise-induced myocardial ischaemia detected by cardiopulmonary exercise testing. Eur Heart J 2003 Jul;24(14):1304-13.
81. Macaciel RM, Mesquita ET, Vivacqua R, Serra S, Campos A, Miranda M, et al. Safety, feasibility, and results of exercise testing for stratifying patients with chest pain in the emergency room. Arq Bras Cardiol 2003 Aug;81(2):174-73.
82. Myers J, Bader D, Madhavan R, Froelicher V. Validation of a specific activity questionnaire to estimate exercise tolerance in patients referred for exercise testing. Am Heart J 2001 Dec;142(6):1041-6.
83. Cole CR, Blackstone EH, Pashkow FJ, Snader CE, Lauer MS. Heart-rate recovery immediately after exercise as a predictor of mortality. N Engl J Med 1999 Oct 28;341(18):1351-7.
84. Sanchis J, Bodi V, Nunez J, Bertomeu-Gonzalez V, Gomez C, Consuegra L, et al. Usefulness of early exercise testing and clinical risk score for prognostic evaluation in chest pain units without preexisting evidence of myocardial ischemia. Am J Cardiol 2006 Mar 1;97(5):633-5.
85. Peels CH, Visser CA, Kupper AJ, Visser FC, Roos JP. Usefulness of two-dimensional echocardiography for immediate detection of myocardial ischemia in the emergency room. Am J Cardiol 1990 Mar 15;65(11):687-91.
86. Sabia P, Abbott RD, Afrookteh A, Keller MW, Touchstone DA, Kaul S. Importance of two-dimensional echocardiographic assessment of left ventricular systolic function in patients presenting to the emergency room with cardiac-related symptoms. Circulation 1991 Oct;84(4):1615-24.
87. Sabia P, Afrookteh A, Touchstone DA, Keller MW, Esquivel L, Kaul S. Value of regional wall motion abnormality in the emergency room diagnosis of acute myocardial infarction. A prospective study using two-dimensional echocardiography. Circulation 1991 Sep;84(3 Suppl):I85-I92.
88. Feigenbaum H. Role of echocardiography in acute myocardial infarction. Am J Cardiol 1990 Nov 20;66(18):17H-22H.
89. Parisi AF. The case for echocardiography in acute myocardial infarction. J Am Soc Echocardiogr 1988 May;1(3):173-8.
90. Reeder GS, Seward JB, Tajik AJ. The role of two-dimensional echocardiography in coronary artery disease: a critical appraisal. Mayo Clin Proc 1982 Apr;57(4):247-58.
91. Gibson RS, Bishop HL, Stamm RB, Crampton RS, Beller GA, Martin RP. Value of early two dimensional echocardiography in patients with acute myocardial infarction. Am J Cardiol 1982 Apr 1;49(5):1110-9.
92. Visser CA, Lie KI, Kan G, Meltzer R, Durrer D. Detection and quantification of acute, isolated myocardial infarction by two dimensional echocardiography. Am J Cardiol 1981 May;47(5):1020-5.
93. Heger JJ, Weyman AE, Wann LS, Rogers EW, Dillon JC, Feigenbaum H. Cross-sectional echocardiographic analysis of the extent of left ventricular asynergy in acute myocardial infarction. Circulation 1980 Jun;61(6):1113-8.
94. Ryan T, Vasey CG, Presti CF, O'Donnell JA, Feigenbaum H, Armstrong WF. Exercise echocardiography: detection of coronary artery disease in patients with normal left ventricular wall motion at rest. J Am Coll Cardiol 1988 May;11(5):993-9.
95. Sawada SG, Ryan T, Conley MJ, Corya BC, Feigenbaum H, Armstrong WF. Prognostic value of a normal exercise echocardiogram. Am Heart J 1990 Jul;120(1):49-55.
96. Cheitlin MD, Alpert JS, Armstrong WF, Aurigemma GP, Beller GA, Bierman FZ, et al. ACC/AHA Guidelines for the Clinical Application of Echocardiography. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Clinical Application of Echocardiography). Developed in collaboration with the American Society of Echocardiography. Circulation 1997 Mar 18;95(6):1686-744.
97. Kloner RA, Parisi AF. Acute myocardial infarction: diagnostic and prognostic applications of two-dimensional echocardiography. Circulation 1987 Mar;75(3):521-4.
98. Fleischmann KE, Goldman L, Robiolio PA, Lee RT, Johnson PA, Cook EF, et al. Echocardiographic correlates of survival in patients with chest pain. J Am Coll Cardiol 1994 May;23(6):1390-6.
99. Mohler ER, III, Ryan T, Segar DS, Sawada SG, Sonel AF, Perkins L, et al. Clinical utility of troponin T levels and echocardiography in the emergency department. Am Heart J 1998 Feb;135(2 Pt 1):253-60.
100. Lee TH, Cook EF, Weisberg M, Sargent RK, Wilson C, Goldman L. Acute chest pain in the emergency room. Identification and examination of low-risk patients. Arch Intern Med 1985 Jan;145(1):65-9.
101. Goldman L, Cook EF, Johnson PA, Brand DA, Rouan GW, Lee TH. Prediction of the need for intensive care in patients who come to the emergency departments with acute chest pain. N Engl J Med 1996 Jun 6;334(23):1498-504.
102. Rizik DG, Healy S, Margulis A, Vandam D, Bakalyar D, Timmis G, et al. A new clinical classification for hospital prognosis of unstable angina pectoris. Am J Cardiol 1995 May 15;75(15):993-7.
103. Lewis WR, Amsterdam EA. Evaluation of the patient with 'rule out myocardial infarction'. Arch Intern Med 1996 Jan 8;156(1):41-5.
104. Katz DA, Griffith JL, Beshansky JR, Selker HP. The use of empiric clinical data in the evaluation of practice guidelines for unstable angina. JAMA 1996 Nov 20;276(19):1568-74.
105. Visser CA, David GK, Kan G, Romijn KH, Meltzer RS, Koolen JJ, et al. Two-dimensional echocardiography during percutaneous transluminal coronary angioplasty. Am Heart J 1986 Jun;111(6):1035-41.
106. Hauser AM, Gangadharan V, Ramos RG, Gordon S, Timmis GC. Sequence of mechanical, electrocardiographic and clinical effects of repeated coronary artery occlusion in human beings: echocardiographic observations during coronary angioplasty. J Am Coll Cardiol 1985 Feb;5(2 Pt 1):193-7.
107. Nixon JV, Brown CN, Smitherman TC. Identification of transient and persistent segmental wall motion abnormalities in patients with unstable angina by two-dimensional echocardiography. Circulation 1982 Jun;65(7):1497-503.
108. Oh JK, Meloy TD, Seward JB. Echocardiography in the emergency room: is it feasible, beneficial, and cost-effective? Echocardiography 1995 Mar;12(2):163-70.
109. Stein JH, Neumann A, Preston LM, VandenBerg BJ, Parrillo JE, Calvin JE, et al. Improved risk stratification in unstable angina: identification of patients at low risk for in-hospital cardiac events by admission echocardiography. Clin Cardiol 1998 Oct;21(10):725-30.
110. Lin SS, Lauer MS, Marwick TH. Risk stratification of patients with medically treated unstable angina using exercise echocardiography. Am J Cardiol 1998 Sep 15;82(6):720-4.
111. Trippi JA, Kopp G, Lee KS, Morrison H, Risk G, Jones JH, et al. The feasibility of dobutamine stress echocardiography in the emergency department with telemedicine interpretation. J Am Soc Echocardiogr 1996 Mar;9(2):113-8.
112. Colon PJ, III, Guarisco JS, Murgo J, Cheirif J. Utility of stress echocardiography in the triage of patients with atypical chest pain from the emergency department. Am J Cardiol 1998 Nov 15;82(10):1282-4, A10.
113. Sitges M, Pare C, Azqueta M, Bosch X, Miranda-Guardiola F, Velamazan M, et al. Feasibility and prognostic value of dobutamine-atropine stress echocardiography early in unstable angina. Eur Heart J 2000 Jul;21(13):1063-71.
114. Varetto T, Cantalupi D, Altieri A, Orlandi C. Emergency room technetium-99m sestamibi imaging to rule out acute myocardial ischemic events in patients with nondiagnostic electrocardiograms. J Am Coll Cardiol 1993 Dec;22(7):1804-8.
115. Hilton TC, Thompson RC, Williams HJ, Saylors R, Fulmer H, Stowers SA. Technetium-99m sestamibi myocardial perfusion imaging in the emergency room evaluation of chest pain. J Am Coll Cardiol 1994 Apr;23(5):1016-22.
116. Stratmann HG, Tamesis BR, Younis LT, Wittry MD, Amato M, Miller DD. Prognostic value of predischarge dipyridamole technetium 99m sestamibi myocardial tomography in medically treated patients with unstable angina. Am Heart J 1995 Oct;130(4):734-40.
117. Hilton TC, Fulmer H, Abuan T, Thompson RC, Stowers SA. Ninety-day follow-up of patients in the emergency department with chest pain who undergo initial single-photon emission computed tomographic perfusion scintigraphy with technetium 99m-labeled sestamibi. J Nucl Cardiol 1996 Jul;3(4):308-11.
118. Radensky PW, Hilton TC, Fulmer H, McLaughlin BA, Stowers SA. Potential cost effectiveness of initial myocardial perfusion imaging for assessment of emergency department patients with chest pain. Am J Cardiol 1997 Mar 1;79(5):595-9.
119. Jain D, Thompson B, Wackers FJ, Zaret BL. Relevance of increased lung thallium uptake on stress imaging in patients with unstable angina and non-Q wave myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI)-IIIB Study. J Am Coll Cardiol 1997 Aug;30(2):421-9.
120. Geleijnse ML, Elhendy A, van Domburg RT, Cornel JH, Rambaldi R, Salustri A, et al. Cardiac imaging for risk stratification with dobutamine-atropine stress testing in patients with chest pain. Echocardiography, perfusion scintigraphy, or both? Circulation 1997 Jul 1;96(1):137-47.
121. Kontos MC, Jesse RL, Schmidt KL, Ornato JP, Tatum JL. Value of acute rest sestamibi perfusion imaging for evaluation of patients admitted to the emergency department with chest pain. J Am Coll Cardiol 1997 Oct;30(4):976-82.
122. Iskander S, Iskandrian AE. Risk assessment using single-photon emission computed tomographic technetium-99m sestamibi imaging. J Am Coll Cardiol 1998 Jul;32(1):57-62.
123. Heller GV, Stowers SA, Hendel RC, Herman SD, Daher E, Ahlberg AW, et al. Clinical value of acute rest technetium-99m tetrofosmin tomographic myocardial perfusion imaging in patients with acute chest pain and nondiagnostic electrocardiograms. J Am Coll Cardiol 1998 Apr;31(5):1011-7.
124. Brown KA. Do stress echocardiography and myocardial perfusion imaging have the same ability to identify the low-risk patient with known or suspected coronary artery disease? Am J Cardiol 1998 Apr 15;81(8):1050-3.
125. Polanczyk CA, Johnson PA, Hartley LH, Walls RM, Shaykevich S, Lee TH. Clinical correlates and prognostic significance of early negative exercise tolerance test in patients with acute chest pain seen in the hospital emergency department. Am J Cardiol 1998 Feb 1;81(3):288-92.
126. Kontos MC, Jesse RL, Anderson FP, Schmidt KL, Ornato JP, Tatum JL. Comparison of myocardial perfusion imaging and cardiac troponin I in patients admitted to the emergency department with chest pain. Circulation 1999 Apr 27;99(16):2073-8.
127. Lee TH, Goldman L. Evaluation of the patient with acute chest pain. N Engl J Med 2000 Apr 20;342(16):1187-95.
128. Stowers SA, Eisenstein EL, Th Wackers FJ, Berman DS, Blackshear JL, Jones AD, Jr., et al. An economic analysis of an aggressive diagnostic strategy with single photon emission computed tomography myocardial perfusion imaging and early exercise stress testing in emergency department patients who present with chest pain but nondiagnostic electrocardiograms: results from a randomized trial. Ann Emerg Med 2000 Jan;35(1):17-25.
129. Pope JH, Aufderheide TP, Ruthazer R, Woolard RH, Feldman JA, Beshansky JR, et al. Missed diagnoses of acute cardiac ischemia in the emergency department. N Engl J Med 2000 Apr 20;342(16):1163-70.
130. Canto JG, Shlipak MG, Rogers WJ, Malmgren JA, Frederick PD, Lambrew CT, et al. Prevalence, clinical characteristics, and mortality among patients with myocardial infarction presenting without chest pain. JAMA 2000 Jun 28;283(24):3223-9.
131. Chalella W.A, Camargo E.E., Marin-Neto J.A., Meneghetti J.C. Atualização da Diretriz da Sociedade Brasileira de Cardiologia sobre Cardiologia Nuclear. Arq Brasil Cardiol http://publicacoes.cardiol.br/ consenso/2005/dircardiologianuclear.pdf . 2005. Ref Type: Generic
132. Kapetanopoulos A, Heller GV, Selker HP, Ruthazer R, Beshansky JR, Feldman JA, et al. Acute resting myocardial perfusion imaging in patients with diabetes mellitus: results from the Emergency Room Assessment of Sestamibi for Evaluation of Chest Pain (ERASE Chest Pain) trial. J Nucl Cardiol 2004 Sep;11(5):570-7.
133. Maroko PR, Radvany P, Braunwald E, Hale SL. Reduction of infarct size by oxygen inhalation following acute coronary occlusion. Circulation 1975 Sep;52(3):360-8.
134. Madias JE, Hood WB, Jr. Reduction of precordial ST-segment elevation in patients with anterior myocardial infarction by oxygen breathing. Circulation 1976 Mar;53(3 Suppl):I198-I200.
135. Dixon RA, Edwards IR, Pilcher J. Diazepam in immediate post-myocardial infarct period. A double blind trial. Br Heart J 1980 May;43(5):535-40.
136. DePace NL, Herling IM, Kotler MN, Hakki AH, Spielman SR, Segal BL. Intravenous nitroglycerin for rest angina. Potential pathophysiologic mechanisms of action. Arch Intern Med 1982 Oct;142(10):1806-9.
137. Kaplan K, Davison R, Parker M, Przybylek J, Teagarden JR, Lesch M. Intravenous nitroglycerin for the treatment of angina at rest unresponsive to standard nitrate therapy. Am J Cardiol 1983 Mar 1;51(5):694-8.
138. Roubin GS, Harris PJ, Eckhardt I, Hensley W, Kelly DT. Intravenous nitroglycerine in refractory unstable angina pectoris. Aust N Z J Med 1982 Dec;12(6):598-602.
139. Curfman GD, Heinsimer JA, Lozner EC, Fung HL. Intravenous nitroglycerin in the treatment of spontaneous angina pectoris: a prospective, randomized trial. Circulation 1983 Feb;67(2):276-82.
140. Dellborg M, Gustafsson G, Swedberg K. Buccal versus intravenous nitroglycerin in unstable angina pectoris. Eur J Clin Pharmacol 1991;41(1):5-9.
141. Gottlieb SO, Weisfeldt ML, Ouyang P, Achuff SC, Baughman KL, Traill TA, et al. Effect of the addition of propranolol to therapy with nifedipine for unstable angina pectoris: a randomized, double-blind, placebo-controlled trial. Circulation 1986 Feb;73(2):331-7.
142. Telford AM, Wilson C. Trial of heparin versus atenolol in prevention of myocardial infarction in intermediate coronary syndrome. Lancet 1981 Jun 6;1(8232):1225-8.
143. Lubsen J, Tijssen JG. Efficacy of nifedipine and metoprolol in the early treatment of unstable angina in the coronary care unit: findings from the Holland Interuniversity Nifedipine/metoprolol Trial (HINT). Am J Cardiol 1987 Jul 15;60(2):18A-25A.
144. Yusuf S, Wittes J, Friedman L. Overview of results of randomized clinical trials in heart disease. II. Unstable angina, heart failure, primary prevention with aspirin, and risk factor modification. JAMA 1988 Oct 21;260(15):2259-63.
145. Chen ZM, Pan HC, Chen YP, Peto R, Collins R, Jiang LX, et al. Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial. Lancet 2005 Nov 5;366(9497):1622-32.
146. Theroux P, Taeymans Y, Morissette D, Bosch X, Pelletier GB, Waters DD. A randomized study comparing propranolol and diltiazem in the treatment of unstable angina. J Am Coll Cardiol 1985 Mar;5(3):717-22.
147. Parodi O, Simonetti I, Michelassi C, Carpeggiani C, Biagini A, L'Abbate A, et al. Comparison of verapamil and propranolol therapy for angina pectoris at rest: a randomized, multiple-crossover, controlled trial in the coronary care unit. Am J Cardiol 1986 Apr 15;57(11):899-906.
148. Held PH, Yusuf S, Furberg CD. Calcium channel blockers in acute myocardial infarction and unstable angina: an overview. BMJ 1989 Nov 11;299(6709):1187-92.
149. Smith NL, Reiber GE, Psaty BM, Heckbert SR, Siscovick DS, Ritchie JL, et al. Health outcomes associated with beta-blocker and diltiazem treatment of unstable angina. J Am Coll Cardiol 1998 Nov;32(5):1305-11.
150. Yusuf S, Held P, Furberg C. Update of effects of calcium antagonists in myocardial infarction or angina in light of the second Danish Verapamil Infarction Trial (DAVIT-II) and other recent studies. Am J Cardiol 1991 Jun 1;67(15):1295-7.
151. Boden WE, van Gilst WH, Scheldewaert RG, Starkey IR, Carlier MF, Julian DG, et al. Diltiazem in acute myocardial infarction treated with thrombolytic agents: a randomised placebo-controlled trial. Incomplete Infarction Trial of European Research Collaborators Evaluating Prognosis post-Thrombolysis (INTERCEPT). Lancet 2000 May 20;355(9217):1751-6.
152. Lewis HD, Jr., Davis JW, Archibald DG, Steinke WE, Smitherman TC, Doherty JE, III, et al. Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina. Results of a Veterans Administration Cooperative Study. N Engl J Med 1983 Aug 18;309(7):396-403.
153. Cairns JA, Gent M, Singer J, Finnie KJ, Froggatt GM, Holder DA, et al. Aspirin, sulfinpyrazone, or both in unstable angina. Results of a Canadian multicenter trial. N Engl J Med 1985 Nov 28;313(22):1369-75.
154. Risk of myocardial infarction and death during treatment with low dose aspirin and intravenous heparin in men with unstable coronary artery disease. The RISC Group. Lancet 1990 Oct 6;336(8719):827-30.
155. Theroux P, Ouimet H, McCans J, Latour JG, Joly P, Levy G, et al. Aspirin, heparin, or both to treat acute unstable angina. N Engl J Med 1988 Oct 27;319(17):1105-11.
156. Clarke RJ, Mayo G, Price P, FitzGerald GA. Suppression of thromboxane A2 but not of systemic prostacyclin by controlled-release aspirin. N Engl J Med 1991 Oct 17;325(16):1137-41.
157. Balsano F, Rizzon P, Violi F, Scrutinio D, Cimminiello C, Aguglia F, et al. Antiplatelet treatment with ticlopidine in unstable angina. A controlled multicenter clinical trial. The Studio della Ticlopidina nell'Angina Instabile Group. Circulation 1990 Jul;82(1):17-26.
158. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee. Lancet 1996 Nov 16;348(9038):1329-39.
159. Yusuf S, Zhao F, Mehta SR, Chrolavicius S, Tognoni G, Fox KK. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 2001 Aug 16;345(7):494-502.
160. Yusuf S, Mehta SR, Zhao F, Gersh BJ, Commerford PJ, Blumenthal M, et al. Early and late effects of clopidogrel in patients with acute coronary syndromes. Circulation 2003 Feb 25;107(7):966-72.
161. Mehta SR, Yusuf S, Peters RJ, Bertrand ME, Lewis BS, Natarajan MK, et al. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet 2001 Aug 18;358(9281):527-33.
162. Peters RJ, Mehta SR, Fox KA, Zhao F, Lewis BS, Kopecky SL, et al. Effects of aspirin dose when used alone or in combination with clopidogrel in patients with acute coronary syndromes: observations from the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) study. Circulation 2003 Oct 7;108(14):1682-7.
163. Leon MB, Baim DS, Popma JJ, Gordon PC, Cutlip DE, Ho KK, et al. A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators. N Engl J Med 1998 Dec 3;339(23):1665-71.
164. Steinhubl SR, Berger PB, Mann JT, III, Fry ET, DeLago A, Wilmer C, et al. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. JAMA 2002 Nov 20;288(19):2411-20.
165. Grines CL, Bonow RO, Casey DE, Jr., Gardner TJ, Lockhart PB, Moliterno DJ, et al. Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians. J Am Coll Cardiol 2007 Feb 13;49(6):734-9.
166. Novel dosing regimen of eptifibatide in planned coronary stent implantation (ESPRIT): a randomised, placebo-controlled trial. Lancet 2000 Dec 16;356(9247):2037-44.
167. A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina. Platelet Receptor Inhibition in Ischemic Syndrome Management (PRISM) Study Investigators. N Engl J Med 1998 May 21;338(21):1498-505.
168. International, randomized, controlled trial of lamifiban (a platelet glycoprotein IIb/IIIa inhibitor), heparin, or both in unstable angina. The PARAGON Investigators. Platelet IIb/IIIa Antagonism for the Reduction of Acute coronary syndrome events in a Global Organization Network. Circulation 1998 Jun 23;97(24):2386-95.
169. Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes. The PURSUIT Trial Investigators. Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy. N Engl J Med 1998 Aug 13;339(7):436-43.
170. Mukherjee D, Mahaffey KW, Moliterno DJ, Harrington RA, Yadav JS, Pieper KS, et al. Promise of combined low-molecular-weight heparin and platelet glycoprotein IIb/IIIa inhibition: results from Platelet IIb/IIIa Antagonist for the Reduction of Acute coronary syndrome events in a Global Organization Network B (PARAGON B). Am Heart J 2002 Dec;144(6):995-1002.
171. Simoons ML. Effect of glycoprotein IIb/IIIa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularisation: the GUSTO IV-ACS randomised trial. Lancet 2001 Jun 16;357(9272):1915-24.
172. Boersma E, Harrington RA, Moliterno DJ, White H, Theroux P, Van de WF, et al. Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials. Lancet 2002 Jan 19;359(9302):189-98.
173. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. The EPIC Investigation. N Engl J Med 1994 Apr 7;330(14):956-61.
174. Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: the CAPTURE Study. Lancet 1997 May 17;349(9063):1429-35.
175. Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization. The EPILOG Investigators. N Engl J Med 1997 Jun 12;336(24):1689-96.
176. Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade. The EPISTENT Investigators. Evaluation of Platelet IIb/IIIa Inhibitor for Stenting. Lancet 1998 Jul 11;352(9122):87-92.
177. Randomised placebo-controlled trial of effect of eptifibatide on complications of percutaneous coronary intervention: IMPACT-II. Integrilin to Minimise Platelet Aggregation and Coronary Thrombosis-II. Lancet 1997 May 17;349(9063):1422-8.
178. Effects of platelet glycoprotein IIb/IIIa blockade with tirofiban on adverse cardiac events in patients with unstable angina or acute myocardial infarction undergoing coronary angioplasty. The RESTORE Investigators. Randomized Efficacy Study of Tirofiban for Outcomes and REstenosis. Circulation 1997 Sep 2;96(5):1445-53.
179. O'Shea JC, Hafley GE, Greenberg S, Hasselblad V, Lorenz TJ, Kitt MM, et al. Platelet glycoprotein IIb/IIIa integrin blockade with eptifibatide in coronary stent intervention: the ESPRIT trial: a randomized controlled trial. JAMA 2001 May 16;285(19):2468-73.
180. Kastrati A, Mehilli J, Neumann FJ, Dotzer F, ten BJ, Bollwein H, et al. Abciximab in patients with acute coronary syndromes undergoing percutaneous coronary intervention after clopidogrel pretreatment: the ISAR-REACT 2 randomized trial. JAMA 2006 Apr 5;295(13):1531-8.
181. Karvouni E, Katritsis DG, Ioannidis JP. Intravenous glycoprotein IIb/IIIa receptor antagonists reduce mortality after percutaneous coronary interventions. J Am Coll Cardiol 2003 Jan 1;41(1):26-32.
182. Stone GW, Bertrand ME, Moses JW, Ohman EM, Lincoff AM, Ware JH, et al. Routine upstream initiation vs deferred selective use of glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: the ACUITY Timing trial. JAMA 2007 Feb 14;297(6):591-602.
183. Stone GW, McLaurin BT, Cox DA, Bertrand ME, Lincoff AM, Moses JW, et al. Bivalirudin for patients with acute coronary syndromes. N Engl J Med 2006 Nov 23;355(21):2203-16.
184. Peterson ED, Pollack CV, Jr., Roe MT, Parsons LS, Littrell KA, Canto JG, et al. Early use of glycoprotein IIb/IIIa inhibitors in non-ST-elevation acute myocardial infarction: observations from the National Registry of Myocardial Infarction 4. J Am Coll Cardiol 2003 Jul 2;42(1):45-53.
185. Bromberg-Marin G, Marin-Neto JA, Parsons LS, Canto JG, Rogers WJ. Effectiveness and safety of glycoprotein IIb/IIIa inhibitors and clopidogrel alone and in combination in non-ST-segment elevation myocardial infarction (from the National Registry of Myocardial Infarction-4). Am J Cardiol 2006 Nov 1;98(9):1125-31.
186. Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 2000 Jan 20;342(3):145-53.
187. Fox KM. Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study). Lancet 2003 Sep 6;362(9386):782-8.
188. Braunwald E, Domanski MJ, Fowler SE, Geller NL, Gersh BJ, Hsia J, et al. Angiotensin-converting-enzyme inhibition in stable coronary artery disease. N Engl J Med 2004 Nov 11;351(20):2058-68.
189. Solomon SD, Rice MM, Jablonski A, Jose P, Domanski M, Sabatine M, et al. Renal function and effectiveness of angiotensin-converting enzyme inhibitor therapy in patients with chronic stable coronary disease in the Prevention of Events with ACE inhibition (PEACE) trial. Circulation 2006 Jul 4;114(1):26-31.
190. Maseri A, Sanna T. The role of plaque fissures in unstable angina: fact or fiction? Eur Heart J 1998 Sep;19 Suppl K:K2-K4.
191. Davies MJ, Thomas AC. Plaque fissuring - the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina. Br Heart J 1985 Apr;53(4):363-73.
192. Fuster V, Badimon L, Cohen M, Ambrose JA, Badimon JJ, Chesebro J. Insights into the pathogenesis of acute ischemic syndromes. Circulation 1988 Jun;77(6):1213-20.
193. Libby P. Molecular bases of the acute coronary syndromes. Circulation 1995 Jun 1;91(11):2844-50.
194. Meade TW, Ruddock V, Stirling Y, Chakrabarti R, Miller GJ. Fibrinolytic activity, clotting factors, and long-term incidence of ischaemic heart disease in the Northwick Park Heart Study. Lancet 1993 Oct 30;342(8879):1076-9.
195. Prins MH, Hirsh J. A critical review of the relationship between impaired fibrinolysis and myocardial infarction. Am Heart J 1991 Aug;122(2):545-51.
196. Thompson SG, Kienast J, Pyke SD, Haverkate F, van de Loo JC. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. N Engl J Med 1995 Mar 9;332(10):635-41.
197. Ardissino D, Merlini PA, Eisenberg PR, Kottke-Marchant K, Crenshaw BS, Granger CB. Coagulation markers and outcomes in acute coronary syndromes. Am Heart J 1998 Oct;136(4 Pt 2 Su):S7-18.
198. Cairns JA, Lewis HD, Jr., Meade TW, Sutton GC, Theroux P. Antithrombotic agents in coronary artery disease. Chest 1995 Oct;108(4 Suppl):380S-400S.
199. Raschke RA, Reilly BM, Guidry JR, Fontana JR, Srinivas S. The weight-based heparin dosing nomogram compared with a "standard care" nomogram. A randomized controlled trial. Ann Intern Med 1993 Nov 1;119(9):874-81.
200. Neri Serneri GG, Gensini GF, Poggesi L, Trotta F, Modesti PA, Boddi M, et al. Effect of heparin, aspirin, or alteplase in reduction of myocardial ischaemia in refractory unstable angina. Lancet 1990 Mar 17;335(8690):615-8.
201. Hirsh J, Levine MN. Low molecular weight heparin. Blood 1992 Jan 1;79(1):1-17.
202. Fareed J, Jeske W, Hoppensteadt D, Clarizio R, Walenga JM. Low-molecular-weight heparins: pharmacologic profile and product differentiation. Am J Cardiol 1998 Sep 10;82(5B):3L-10L.
203. Linhardt RJ, Gunay NS. Production and chemical processing of low molecular weight heparins. Semin Thromb Hemost 1999;25 Suppl 3:5-16.
204. Comparison of two treatment durations (6 days and 14 days) of a low molecular weight heparin with a 6-day treatment of unfractionated heparin in the initial management of unstable angina or non-Q wave myocardial infarction: FRAX.I.S. (FRAxiparine in Ischaemic Syndrome). Eur Heart J 1999 Nov;20(21):1553-62.
205. Low-molecular-weight heparin during instability in coronary artery disease, Fragmin during Instability in Coronary Artery Disease (FRISC) study group. Lancet 1996 Mar 2;347(9001):561-8.
206. Klein W, Buchwald A, Hillis WS, Monrad S, Sanz G, Turpie AG, et al. Fragmin in unstable angina pectoris or in non-Q-wave acute myocardial infarction (the FRIC study). Fragmin in Unstable Coronary Artery Disease. Am J Cardiol 1997 Sep 4;80(5A):30E-4E.
207. Klein W, Buchwald A, Hillis SE, Monrad S, Sanz G, Turpie AG, et al. Comparison of low-molecular-weight heparin with unfractionated heparin acutely and with placebo for 6 weeks in the management of unstable coronary artery disease. Fragmin in unstable coronary artery disease study (FRIC). Circulation 1997 Jul 1;96(1):61-8.
208. Long-term low-molecular-mass heparin in unstable coronary-artery disease: FRISC II prospective randomised multicentre study. FRagmin and Fast Revascularisation during InStability in Coronary artery disease. Investigators. Lancet 1999 Aug 28;354(9180):701-7.
209. Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study. FRagmin and Fast Revascularisation during InStability in Coronary artery disease Investigators. Lancet 1999 Aug 28;354(9180):708-15.
210. Cohen M, Demers C, Gurfinkel EP, Turpie AG, Fromell GJ, Goodman S, et al. A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group. N Engl J Med 1997 Aug 14;337(7):447-52.
211. Theroux P, Waters D, Lam J, Juneau M, McCans J. Reactivation of unstable angina after the discontinuation of heparin. N Engl J Med 1992 Jul 16;327(3):141-5.
212. Goodman SG, Cohen M, Bigonzi F, Gurfinkel EP, Radley DR, Le I, V, et al. Randomized trial of low molecular weight heparin (enoxaparin) versus unfractionated heparin for unstable coronary artery disease: one-year results of the ESSENCE Study. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q Wave Coronary Events. J Am Coll Cardiol 2000 Sep;36(3):693-8.
213. Antman EM, McCabe CH, Gurfinkel EP, Turpie AG, Bernink PJ, Salein D, et al. Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) 11B trial. Circulation 1999 Oct 12;100(15):1593-601.
214. Bozovich GE, Gurfinkel EP, Antman EM, McCabe CH, Mautner B. Superiority of enoxaparin versus unfractionated heparin for unstable angina/non-Q-wave myocardial infarction regardless of activated partial thromboplastin time. Am Heart J 2000 Oct;140(4):637-42.
215. Antman EM, Cohen M, Radley D, McCabe C, Rush J, Premmereur J, et al. Assessment of the treatment effect of enoxaparin for unstable angina/non-Q-wave myocardial infarction. TIMI 11B-ESSENCE meta-analysis. Circulation 1999 Oct 12;100(15):1602-8.
216. Cohen M, Theroux P, Borzak S, Frey MJ, White HD, Van Mieghem W, et al. Randomized double-blind safety study of enoxaparin versus unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes treated with tirofiban and aspirin: the ACUTE II study. The Antithrombotic Combination Using Tirofiban and Enoxaparin. Am Heart J 2002 Sep;144(3):470-7.
217. Ferguson JJ, Califf RM, Antman EM, Cohen M, Grines CL, Goodman S, et al. Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial. JAMA 2004 Jul 7;292(1):45-54.
218. Blazing MA, de Lemos JA, White HD, Fox KA, Verheugt FW, Ardissino D, et al. Safety and efficacy of enoxaparin vs unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes who receive tirofiban and aspirin: a randomized controlled trial. JAMA 2004 Jul 7;292(1):55-64.
219. Mahaffey KW, Cohen M, Garg J, Antman E, Kleiman NS, Goodman SG, et al. High-risk patients with acute coronary syndromes treated with low-molecular-weight or unfractionated heparin: outcomes at 6 months and 1 year in the SYNERGY trial. JAMA 2005 Nov 23;294(20):2594-600.
220. Petersen JL, Mahaffey KW, Hasselblad V, Antman EM, Cohen M, Goodman SG, et al. Efficacy and bleeding complications among patients randomized to enoxaparin or unfractionated heparin for antithrombin therapy in non-ST-Segment elevation acute coronary syndromes: a systematic overview. JAMA 2004 Jul 7;292(1):89-96.
221. Furberg CD, Herrington DM, Psaty BM. Are drugs within a class interchangeable? Lancet 1999 Oct 2;354(9185):1202-4.
222. Fareed J, Walenga JM, Hoppensteadt D, Huan X, Nonn R. Biochemical and pharmacologic inequivalence of low molecular weight heparins. Ann N Y Acad Sci 1989;556:333-53.
223. Fareed J, Jeske W, Hoppensteadt D, Clarizio R, Walenga JM. Are the available low-molecular-weight heparin preparations the same? Semin Thromb Hemost 1996;22 Suppl 1:77-91.
224. Fareed J, Haas S, Sasahar A. Past, present and future considerations on low molecular weight heparin differentiation: an epilogue. Semin Thromb Hemost 1999;25 Suppl 3:145-7.
225. Montalescot G, Collet JP, Lison L, Choussat R, Ankri A, Vicaut E, et al. Effects of various anticoagulant treatments on von Willebrand factor release in unstable angina. J Am Coll Cardiol 2000 Jul;36(1):110-4.
226. Montalescot G, Philippe F, Ankri A, Vicaut E, Bearez E, Poulard JE, et al. Early increase of von Willebrand factor predicts adverse outcome in unstable coronary artery disease: beneficial effects of enoxaparin. French Investigators of the ESSENCE Trial. Circulation 1998 Jul 28;98(4):294-9.
227. Kaul S, Shah PK. Low molecular weight heparin in acute coronary syndrome: evidence for superior or equivalent efficacy compared with unfractionated heparin? J Am Coll Cardiol 2000 Jun;35(7):1699-712.
228. Eikelboom JW, Anand SS, Malmberg K, Weitz JI, Ginsberg JS, Yusuf S. Unfractionated heparin and low-molecular-weight heparin in acute coronary syndrome without ST elevation: a meta-analysis. Lancet 2000 Jun 3;355(9219):1936-42.
229. Effects of recombinant hirudin (lepirudin) compared with heparin on death, myocardial infarction, refractory angina, and revascularisation procedures in patients with acute myocardial ischaemia without ST elevation: a randomised trial. Organisation to Assess Strategies for Ischemic Syndromes (OASIS-2) Investigators. Lancet 1999 Feb 6;353(9151):429-38.
230. Kong DF, Topol EJ, Bittl JA, White HD, Theroux P, Hasselblad V, et al. Clinical outcomes of bivalirudin for ischemic heart disease. Circulation 1999 Nov 16;100(20):2049-53.
231. Yusuf S, Mehta SR, Chrolavicius S, Afzal R, Pogue J, Granger CB, et al. Comparison of fondaparinux and enoxaparin in acute coronary syndromes. N Engl J Med 2006 Apr 6;354(14):1464-76.
232. Smith SC, Jr., Feldman TE, Hirshfeld JW, Jr., Jacobs AK, Kern MJ, King SB, III, et al. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention). J Am Coll Cardiol 2006 Jan 3;47(1):e1-121.
233. Marin-Neto J.A., Ayres Neto. Cinecoronariografia: quando não é e quando é preciso indicar. Timerman A, César L.A.M., Ferreira J.F.M., Bertolami M.C., editors. In: Manual de Cardiologia SOCESP. 207-211. 2000. São Paulo, Editora Atheneu. Ref Type: Generic
234. Scull GS, Martin JS, Weaver WD, Every NR. Early angiography versus conservative treatment in patients with non-ST elevation acute myocardial infarction: MITI Investigators. Myocardial Infarction Triage and Intervention. J Am Coll Cardiol 2000 Mar 15;35(4):895-902.
235. Bhatt DL, Roe MT, Peterson ED, Li Y, Chen AY, Harrington RA, et al. Utilization of early invasive management strategies for high-risk patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE Quality Improvement Initiative. JAMA 2004 Nov 3;292(17):2096-104.
236. Fox KA, Goodman SG, Klein W, Brieger D, Steg PG, Dabbous O, et al. Management of acute coronary syndromes. Variations in practice and outcome; findings from the Global Registry of Acute Coronary Events (GRACE). Eur Heart J 2002 Aug;23(15):1177-89.
237. McCullough PA, O'Neill WW, Graham M, Stomel RJ, Rogers F, David S, et al. A prospective randomized trial of triage angiography in acute coronary syndromes ineligible for thrombolytic therapy. Results of the medicine versus angiography in thrombolytic exclusion (MATE) trial. J Am Coll Cardiol 1998 Sep;32(3):596-605.
238. Michalis LK, Stroumbis CS, Pappas K, Sourla E, Niokou D, Goudevenos JA, et al. Treatment of refractory unstable angina in geographically isolated areas without cardiac surgery. Invasive versus conservative strategy (TRUCS study). Eur Heart J 2000 Dec;21(23):1954-9.
239. Spacek R, Widimsky P, Straka Z, Jiresova E, Dvorak J, Polasek R, et al. Value of first day angiography/angioplasty in evolving Non-ST segment elevation myocardial infarction: an open multicenter randomized trial. The VINO Study. Eur Heart J 2002 Feb;23(3):230-8.
240. van 't Hof AW, de Vries ST, Dambrink JH, Miedema K, Suryapranata H, Hoorntje JC, et al. A comparison of two invasive strategies in patients with non-ST elevation acute coronary syndromes: results of the Early or Late Intervention in unStable Angina (ELISA) pilot study. 2b/3a upstream therapy and acute coronary syndromes. Eur Heart J 2003 Aug;24(15):1401-5.
241. Boden WE, O'Rourke RA, Crawford MH, Blaustein AS, Deedwania PC, Zoble RG, et al. Outcomes in patients with acute non-Q-wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy. Veterans Affairs Non-Q-Wave Infarction Strategies in Hospital (VANQWISH) Trial Investigators. N Engl J Med 1998 Jun 18;338(25):1785-92.
242. Cannon CP, Weintraub WS, Demopoulos LA, Vicari R, Frey MJ, Lakkis N, et al. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med 2001 Jun 21;344(25):1879-87.
243. Fox KA, Poole-Wilson PA, Henderson RA, Clayton TC, Chamberlain DA, Shaw TR, et al. Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: the British Heart Foundation RITA 3 randomised trial. Randomized Intervention Trial of unstable Angina. Lancet 2002 Sep 7;360(9335):743-51.
244. Neumann FJ, Kastrati A, Pogatsa-Murray G, Mehilli J, Bollwein H, Bestehorn HP, et al. Evaluation of prolonged antithrombotic pretreatment ("cooling-off" strategy) before intervention in patients with unstable coronary syndromes: a randomized controlled trial. JAMA 2003 Sep 24;290(12):1593-9.
245. de Winter RJ, Windhausen F, Cornel JH, Dunselman PH, Janus CL, Bendermacher PE, et al. Early invasive versus selectively invasive management for acute coronary syndromes. N Engl J Med 2005 Sep 15;353(11):1095-104.
246. Bavry AA, Kumbhani DJ, Quiroz R, Ramchandani SR, Kenchaiah S, Antman EM. Invasive therapy along with glycoprotein IIb/IIIa inhibitors and intracoronary stents improves survival in non-ST-segment elevation acute coronary syndromes: a meta-analysis and review of the literature. Am J Cardiol 2004 Apr 1;93(7):830-5.
247. Biondi-Zoccai GG, Abbate A, Agostoni P, Testa L, Burzotta F, Lotrionte M, et al. Long-term benefits of an early invasive management in acute coronary syndromes depend on intracoronary stenting and aggressive antiplatelet treatment: a metaregression. Am Heart J 2005 Mar;149(3):504-11.
248. Mehta SR, Cannon CP, Fox KA, Wallentin L, Boden WE, Spacek R, et al. Routine vs selective invasive strategies in patients with acute coronary syndromes: a collaborative meta-analysis of randomized trials. JAMA 2005 Jun 15;293(23):2908-17.
249. Lagerqvist B, Husted S, Kontny F, Naslund U, Stahle E, Swahn E, et al. A long-term perspective on the protective effects of an early invasive strategy in unstable coronary artery disease: two-year follow-up of the FRISC-II invasive study. J Am Coll Cardiol 2002 Dec 4;40(11):1902-14.
250. Fox KA, Poole-Wilson P, Clayton TC, Henderson RA, Shaw TR, Wheatley DJ, et al. 5-year outcome of an interventional strategy in non-ST-elevation acute coronary syndrome: the British Heart Foundation RITA 3 randomised trial. Lancet 2005 Sep 10;366(9489):914-20.
251. Bavry AA, Kumbhani DJ, Rassi AN, Bhatt DL, Askari AT. Benefit of early invasive therapy in acute coronary syndromes: a meta-analysis of contemporary randomized clinical trials. J Am Coll Cardiol 2006 Oct 3;48(7):1319-25.
252. Gibbons RJ, Balady GJ, Bricker JT, Chaitman BR, Fletcher GF, Froelicher VF, et al. ACC/AHA 2002 guideline update for exercise testing: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines). Circulation 2002 Oct 1;106(14):1883-92.
253. Gibler WB, Cannon CP, Blomkalns AL, Char DM, Drew BJ, Hollander JE, et al. Practical implementation of the guidelines for unstable angina/non-ST- segment elevation myocardial infarction in the emergency department: a scientific statement from the American Heart Association Council on Clinical Cardiology (Subcommittee on Acute Cardiac Care), Council on Cardiovascular Nursing, and Quality of Care and Outcomes Research Interdisciplinary Working Group, in Collaboration With the Society of Chest Pain Centers. Circulation 2005 May 24;111(20):2699-710.
254. Amsterdam EA, Kirk JD, Diercks DB, Lewis WR, Turnipseed SD. Early exercise testing in the management of low risk patients in chest pain centers. Prog Cardiovasc Dis 2004 Mar;46(5):438-52.
255. Morrow K, Morris CK, Froelicher VF, Hideg A, Hunter D, Johnson E, et al. Prediction of cardiovascular death in men undergoing noninvasive evaluation for coronary artery disease. Ann Intern Med 1993 May 1;118(9):689-95.
256. McNeer JF, Margolis JR, Lee KL, Kisslo JA, Peter RH, Kong Y, et al. The role of the exercise test in the evaluation of patients for ischemic heart disease. Circulation 1978 Jan;57(1):64-70.
257. Weiner DA, Ryan TJ, McCabe CH, Chaitman BR, Sheffield LT, Ferguson JC, et al. Prognostic importance of a clinical profile and exercise test in medically treated patients with coronary artery disease. J Am Coll Cardiol 1984 Mar;3(3):772-9.
258. Nyman I, Larsson H, Areskog M, Areskog NH, Wallentin L. The predictive value of silent ischemia at an exercise test before discharge after an episode of unstable coronary artery disease. RISC Study Group. Am Heart J 1992 Feb;123(2):324-31.
259. Nyman I, Wallentin L, Areskog M, Areskog NH, Swahn E. Risk stratification by early exercise testing after an episode of unstable coronary artery disease. The RISC Study Group. Int J Cardiol 1993 May;39(2):131-42.
260. Lindahl B, Andren B, Ohlsson J, Venge P, Wallentin L. Noninvasive risk stratification in unstable coronary artery disease: exercise test and biochemical markers. FRISC Study Group. Am J Cardiol 1997 Sep 4;80(5A):40E-4E.
261. Butman SM, Olson HG, Gardin JM, Piters KM, Hullett M, Butman LK. Submaximal exercise testing after stabilization of unstable angina pectoris. J Am Coll Cardiol 1984 Oct;4(4):667-73.
262. Mark DB, Hlatky MA, Harrell FE, Jr., Lee KL, Califf RM, Pryor DB. Exercise treadmill score for predicting prognosis in coronary artery disease. Ann Intern Med 1987 Jun;106(6):793-800.
263. Stein RA, Chaitman BR, Balady GJ, Fleg JL, Limacher MC, Pina IL, et al. Safety and utility of exercise testing in emergency room chest pain centers: An advisory from the Committee on Exercise, Rehabilitation, and Prevention, Council on Clinical Cardiology, American Heart Association. Circulation 2000 Sep 19;102(12):1463-7.
264. Larsson H, Areskog M, Areskog NH, Nylander E, Nyman I, Swahn E, et al. Should the exercise test (ET) be performed at discharge or one month later after an episode of unstable angina or non-Q-wave myocardial infarction? Int J Card Imaging 1991;7(1):7-14.
265. Berthe C, Pierard LA, Hiernaux M, Trotteur G, Lempereur P, Carlier J, et al. Predicting the extent and location of coronary artery disease in acute myocardial infarction by echocardiography during dobutamine infusion. Am J Cardiol 1986 Dec 1;58(13):1167-72.
266. Horowitz RS, Morganroth J, Parrotto C, Chen CC, Soffer J, Pauletto FJ. Immediate diagnosis of acute myocardial infarction by two-dimensional echocardiography. Circulation 1982 Feb;65(2):323-9.
267. Kontos MC, Arrowood JA, Paulsen WH, Nixon JV. Early echocardiography can predict cardiac events in emergency department patients with chest pain. Ann Emerg Med 1998 May;31(5):550-7.
268. Gibler WB, Runyon JP, Levy RC, Sayre MR, Kacich R, Hattemer CR, et al. A rapid diagnostic and treatment center for patients with chest pain in the emergency department. Ann Emerg Med 1995 Jan;25(1):1-8.
269. de ZC, Cheriex EC, Braat SH, Stappers JL, Wellens HJ. Improvement of systolic and diastolic left ventricular wall motion by serial echocardiograms in selected patients treated for unstable angina. Am Heart J 1991 Mar;121(3 Pt 1):789-97.
270. Campos FO, Zielinsky P, Ortiz J, Maciel BC, Andrade JL, Mathias W, Jr., et al. [Guideline for indication and utilization of echocardiography in clinical practice]. Arq Bras Cardiol 2004 Jan;82 Suppl 2:11-34.
271. Caldas MA, Tsutsui JM, Kowatsch I, Andrade JL, Nicolau JC, Ramires JF, et al. Value of myocardial contrast echocardiography for predicting left ventricular remodeling and segmental functional recovery after anterior wall acute myocardial infarction. J Am Soc Echocardiogr 2004 Sep;17(9):923-32.
272. Cwajg JM, Cwajg E, Nagueh SF, He ZX, Qureshi U, Olmos LI, et al. End-diastolic wall thickness as a predictor of recovery of function in myocardial hibernation: relation to rest-redistribution T1-201 tomography and dobutamine stress echocardiography. J Am Coll Cardiol 2000 Apr;35(5):1152-61.
273. Picano E, Mathias W, Jr., Pingitore A, Bigi R, Previtali M. Safety and tolerability of dobutamine-atropine stress echocardiography: a prospective, multicentre study. Echo Dobutamine International Cooperative Study Group. Lancet 1994 Oct 29;344(8931):1190-2.
274. Picano E, Sicari R, Landi P, Cortigiani L, Bigi R, Coletta C, et al. Prognostic value of myocardial viability in medically treated patients with global left ventricular dysfunction early after an acute uncomplicated myocardial infarction: a dobutamine stress echocardiographic study. Circulation 1998 Sep 15;98(11):1078-84.
275. Sicari R, Landi P, Picano E, Pirelli S, Chiaranda G, Previtali M, et al. Exercise-electrocardiography and/or pharmacological stress echocardiography for non-invasive risk stratification early after uncomplicated myocardial infarction. A prospective international large scale multicentre study. Eur Heart J 2002 Jul;23(13):1030-7.
276. Mathias W, Jr., Arruda AL, Andrade JL, Filho OC, Porter TR. Endocardial border delineation during dobutamine infusion using contrast echocardiography. Echocardiography 2002 Feb;19(2):109-14.
277. Falcone RA, Marcovitz PA, Perez JE, Dittrich HC, Hopkins WE, Armstrong WF. Intravenous albunex during dobutamine stress echocardiography: enhanced localization of left ventricular endocardial borders. Am Heart J 1995 Aug;130(2):254-8.
278. Tsutsui JM, Elhendy A, Xie F, O'Leary EL, McGrain AC, Porter TR. Safety
279. Tsutsui JM, Xie F, O'Leary EL, Elhendy A, Anderson JR, McGrain AC, et al. Diagnostic accuracy and prognostic value of dobutamine stress myocardial contrast echocardiography in patients with suspected acute coronary syndromes. Echocardiography 2005 Jul;22(6):487-95.
280. Mulvagh SL, DeMaria AN, Feinstein SB, Burns PN, Kaul S, Miller JG, et al. Contrast echocardiography: current and future applications. J Am Soc Echocardiogr 2000 Apr;13(4):331-42.
281. Brown KA. Evaluation of the unstable angina patient in 2005: is there still a role for noninvasive risk stratification? J Nucl Cardiol 2005 Jan;12(1):9-11.
282. Amanullah AM. Noninvasive testing in the diagnosis and management of unstable angina. Int J Cardiol 1994 Dec;47(2):95-103.
283. Miller DD. Risk stratification in unstable angina pectoris. Zaret BL, Beller GA, editors. In: Nuclear Cardiology. State of the art and future directions. 490-499. 1999. St. Louis, Mosby Inc. Ref Type: Generic
284. Allman KC, Freedman SB. Emergency department assessment of patients with acute chest pain: myocardial perfusion imaging, blood tests, or both? J Nucl Cardiol 2004 Jan;11(1):87-9.
285. Udelson JE, Beshansky JR, Ballin DS, Feldman JA, Griffith JL, Handler J, et al. Myocardial perfusion imaging for evaluation and triage of patients with suspected acute cardiac ischemia: a randomized controlled trial. JAMA 2002 Dec 4;288(21):2693-700.
286. Freeman MR, Chisholm RJ, Armstrong PW. Usefulness of exercise electrocardiography and thallium scintigraphy in unstable angina pectoris in predicting the extent and severity of coronary artery disease. Am J Cardiol 1988 Dec 1;62(17):1164-70.
287. Zhu YY, Chung WS, Botvinick EH, Dae MW, Lim AD, Ports TA, et al. Dipyridamole perfusion scintigraphy: the experience with its application in one hundred seventy patients with known or suspected unstable angina. Am Heart J 1991 Jan;121(1 Pt 1):33-43.
288. Brown KA. Prognostic value of thallium-201 myocardial perfusion imaging in patients with unstable angina who respond to medical treatment. J Am Coll Cardiol 1991 Apr;17(5):1053-7.
289. Madsen JK, Stubgaard M, Utne HE, Hansen JF, van DK, Reiber JH, et al. Prognosis and thallium-201 scintigraphy in patients admitted with chest pain without confirmed acute myocardial infarction. Br Heart J 1988 Feb;59(2):184-9.
290. Stratmann HG, Younis LT, Wittry MD, Amato M, Miller DD. Exercise technetium-99m myocardial tomography for the risk stratification of men with medically treated unstable angina pectoris. Am J Cardiol 1995 Aug 1;76(4):236-40.
291. Amanullah AM, Lindvall K, Bevegard S. Prognostic significance of exercise thallium-201 myocardial perfusion imaging compared to stress echocardiography and clinical variables in patients with unstable angina who respond to medical treatment. Int J Cardiol 1993 Apr;39(1):71-8.